Article: Systemic bevacizumab to treat refractory bleeding in hereditary haemorrhagic telangiectasia: A single centre case series

€3.03

SKU: product-article-42794 Category: General

Description
Reviews (0)

Description

Systemic bevacizumab to treat refractory bleeding in hereditary haemorrhagic telangiectasia: A single centre case series

Reviews

There are no reviews yet.

Be the first to review “Article: Systemic bevacizumab to treat refractory bleeding in hereditary haemorrhagic telangiectasia: A single centre case series”

You must be logged in to post a review.

Top

Article: Systemic bevacizumab to treat refractory bleeding in hereditary haemorrhagic telangiectasia: A single centre case series

Description

Reviews

Related products

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Highlights in squamous cell carcinoma of the head and neck

Article: INTRODUCTION

Article: Highlights in breast cancer